Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies — Dan Joseph Stein (2021) | RDL Network
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
Dan Joseph Stein, Antti Ahokas, Marek Jarema, А С Аведисова, L. Vavrušová, Олег Чабан, C. Gruget, Valérie Olivier, F. Picarel-Blanchot, Christian de Bodinat
Discussion(0)
No comments yet. Be the first to comment.